DK0954305T3 - Anvendelse af carbonanhydraseinhibitorer til behandling af maculaødem - Google Patents

Anvendelse af carbonanhydraseinhibitorer til behandling af maculaødem

Info

Publication number: DK0954305T3
Authority: DK; Denmark
Prior art keywords: carbonic anhydrase; treatment; macular edema; anhydrase inhibitors; cai
Prior art date: 1996-02-26

Application number

DK97907822T

Other languages

English (en)

Inventor

Alon Harris

William Eric Sponsel

Original Assignee

Advanced Res & Tech Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-26

Filing date

1997-02-25

Publication date

2003-08-25

1996-03-18 Priority claimed from GBGB9605642.9A external-priority patent/GB9605642D0/en

1997-02-25 Application filed by Advanced Res & Tech Inst filed Critical Advanced Res & Tech Inst

2003-08-25 Application granted granted Critical

2003-08-25 Publication of DK0954305T3 publication Critical patent/DK0954305T3/da

Links

239000003489 carbonate dehydratase inhibitor Substances 0.000 title abstract 3
206010025415 Macular oedema Diseases 0.000 title abstract 2
201000010230 macular retinal edema Diseases 0.000 title abstract 2
208000001344 Macular Edema Diseases 0.000 title 1
229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 title 1
229940122072 Carbonic anhydrase inhibitor Drugs 0.000 abstract 2
206010064930 age-related macular degeneration Diseases 0.000 abstract 1
208000002780 macular degeneration Diseases 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Eye Examination Apparatus (AREA)

DK97907822T 1996-02-26 1997-02-25 Anvendelse af carbonanhydraseinhibitorer til behandling af maculaødem DK0954305T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1225096P	1996-02-26	1996-02-26
GBGB9605642.9A GB9605642D0 (en)	1996-03-18	1996-03-18	Treatment of macular edema
PCT/US1997/002874 WO1997030704A2 (en)	1996-02-26	1997-02-25	Use of carbonic anhydrase inhibitors for treating macular edema

Publications (1)

Publication Number	Publication Date
DK0954305T3 true DK0954305T3 (da)	2003-08-25

Family

ID=26308946

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97907822T DK0954305T3 (da)	1996-02-26	1997-02-25	Anvendelse af carbonanhydraseinhibitorer til behandling af maculaødem

Country Status (26)

Country	Link
EP (1)	EP0954305B9 (da)
JP (1)	JP4392481B2 (da)
KR (1)	KR100471586B1 (da)
CN (1)	CN1225582A (da)
AT (1)	ATE239468T1 (da)
AU (1)	AU727565B2 (da)
BG (1)	BG64525B1 (da)
BR (1)	BR9707674A (da)
CA (1)	CA2247063C (da)
CZ (1)	CZ299509B6 (da)
DE (1)	DE69721824T2 (da)
DK (1)	DK0954305T3 (da)
EA (1)	EA001681B1 (da)
EE (1)	EE03804B1 (da)
ES (1)	ES2199348T4 (da)
HU (1)	HU227161B1 (da)
IL (1)	IL125912A0 (da)
IS (1)	IS2053B (da)
MX (1)	MXPA98006961A (da)
NO (1)	NO320043B1 (da)
NZ (1)	NZ331843A (da)
PT (1)	PT954305E (da)
SK (1)	SK284371B6 (da)
TR (1)	TR199801665T2 (da)
WO (1)	WO1997030704A2 (da)
YU (1)	YU49422B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9716657D0 (en)	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
GB9803226D0 (en)	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
CA2323749A1 (en) *	1998-03-06	1999-09-10	William E. Sponsel	Composition and method for treating macular disorders
US5948801A (en) *	1998-03-09	1999-09-07	Alcon Laboratories, Inc.	Treatment of retinal edema with brinzolamide
CN1311684A (zh) *	1998-07-10	2001-09-05	悉尼大学	黄斑变性中新生血管形成的预防治疗
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902459D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902455D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902461D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0000625D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
US20030100594A1 (en) *	2001-08-10	2003-05-29	Pharmacia Corporation	Carbonic anhydrase inhibitor
US20100063035A1 (en)	2006-12-15	2010-03-11	Nicox S.A.	Carbonic anhydrase inhibitors derivatives
AR084194A1 (es) *	2010-12-09	2013-04-24	Fovea Pharmaceuticals	Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos
AU2017382176A1 (en)	2016-12-21	2019-05-30	Biotheryx, Inc.	Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4797413A (en) *	1986-05-14	1989-01-10	Merck & Co., Inc.	Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
GB2223166B (en) *	1988-09-29	1992-03-18	American Cyanamid Co	Stable ophthalmic preparations containing methazolamide
US5153192A (en) *	1990-04-09	1992-10-06	Alcon Laboratories, Inc.	Thiophene sulfonamides useful as carbonic anhydrase inhibitors

1997
- 1997-02-25 WO PCT/US1997/002874 patent/WO1997030704A2/en not_active Ceased
- 1997-02-25 CZ CZ0269998A patent/CZ299509B6/cs not_active IP Right Cessation
- 1997-02-25 EA EA199800764A patent/EA001681B1/ru not_active IP Right Cessation
- 1997-02-25 EE EE9800263A patent/EE03804B1/xx not_active IP Right Cessation
- 1997-02-25 DK DK97907822T patent/DK0954305T3/da active
- 1997-02-25 IL IL12591297A patent/IL125912A0/xx not_active IP Right Cessation
- 1997-02-25 DE DE69721824T patent/DE69721824T2/de not_active Expired - Lifetime
- 1997-02-25 AT AT97907822T patent/ATE239468T1/de not_active IP Right Cessation
- 1997-02-25 PT PT97907822T patent/PT954305E/pt unknown
- 1997-02-25 JP JP53037997A patent/JP4392481B2/ja not_active Expired - Fee Related
- 1997-02-25 MX MXPA98006961A patent/MXPA98006961A/es active IP Right Grant
- 1997-02-25 SK SK1151-98A patent/SK284371B6/sk not_active IP Right Cessation
- 1997-02-25 BR BR9707674-0A patent/BR9707674A/pt not_active Application Discontinuation
- 1997-02-25 KR KR10-1998-0706643A patent/KR100471586B1/ko not_active Expired - Fee Related
- 1997-02-25 CN CN97192579A patent/CN1225582A/zh active Pending
- 1997-02-25 HU HU9902054A patent/HU227161B1/hu not_active IP Right Cessation
- 1997-02-25 NZ NZ331843A patent/NZ331843A/xx not_active IP Right Cessation
- 1997-02-25 CA CA002247063A patent/CA2247063C/en not_active Expired - Fee Related
- 1997-02-25 YU YU35398A patent/YU49422B/sh unknown
- 1997-02-25 ES ES97907822T patent/ES2199348T4/es not_active Expired - Lifetime
- 1997-02-25 EP EP97907822A patent/EP0954305B9/en not_active Expired - Lifetime
- 1997-02-25 TR TR1998/01665T patent/TR199801665T2/xx unknown
- 1997-02-25 AU AU19721/97A patent/AU727565B2/en not_active Ceased
1998
- 1998-08-20 IS IS4829A patent/IS2053B/is unknown
- 1998-08-25 NO NO19983906A patent/NO320043B1/no not_active IP Right Cessation
- 1998-09-25 BG BG102797A patent/BG64525B1/bg unknown

Also Published As

Publication number	Publication date
WO1997030704A3 (en)	1997-09-25
IS2053B (is)	2005-10-14
NZ331843A (en)	2000-09-29
YU35398A (sh)	2001-12-26
JP2000506833A (ja)	2000-06-06
IL125912A0 (en)	1999-04-11
MXPA98006961A (es)	2004-11-19
ES2199348T3 (es)	2004-02-16
EE9800263A (et)	1999-08-16
CZ269998A3 (cs)	2000-01-12
BG64525B1 (bg)	2005-06-30
CA2247063C (en)	2004-01-06
EE03804B1 (et)	2002-08-15
HU227161B1 (en)	2010-09-28
SK284371B6 (sk)	2005-02-04
CN1225582A (zh)	1999-08-11
AU727565B2 (en)	2000-12-14
DE69721824D1 (de)	2003-06-12
EA199800764A1 (ru)	1999-06-24
BG102797A (en)	1999-09-30
DE69721824T2 (de)	2004-03-11
JP4392481B2 (ja)	2010-01-06
ATE239468T1 (de)	2003-05-15
NO983906D0 (no)	1998-08-25
NO983906L (no)	1998-10-19
IS4829A (is)	1998-08-20
BR9707674A (pt)	2000-01-04
AU1972197A (en)	1997-09-10
PT954305E (pt)	2003-09-30
YU49422B (sh)	2006-01-16
HUP9902054A3 (en)	2001-07-30
CA2247063A1 (en)	1997-08-28
EA001681B1 (ru)	2001-06-25
EP0954305A2 (en)	1999-11-10
EP0954305B9 (en)	2010-08-04
KR100471586B1 (ko)	2005-07-11
WO1997030704A2 (en)	1997-08-28
CZ299509B6 (cs)	2008-08-20
HUP9902054A1 (hu)	2000-03-28
SK115198A3 (en)	2000-01-18
EP0954305B1 (en)	2003-05-07
NO320043B1 (no)	2005-10-17
ES2199348T4 (es)	2010-10-19
KR19990087242A (ko)	1999-12-15
TR199801665T2 (xx)	1998-12-21

Publication	Publication Date	Title
EE9800263A (et)	1999-08-16	Karboanhüdraasi inhibiitorite kasutamine kollatähni turse raviks
DK0719154T3 (da)	2001-11-26	Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
DE69924641D1 (de)	2005-05-12	Behandlung von asthma anhand von mek-inhibitoren
NZ309523A (en)	1999-11-29	Peptidyl heterocycles useful in the treatment of thrombin related disorders
DK1039912T3 (da)	2002-10-28	Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DK0934061T3 (da)	2003-09-22	Isobutylgaba og dets derivater til behandling af smerte
NO992492L (no)	1999-05-25	Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
PT971713E (pt)	2003-09-30	Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
DE60310400D1 (de)	2007-01-25	Botulinustoxine zur behandlung von priapismus
DK91793A (da)	1995-01-31	Fremgangsmåde til overfladebehandling, midler til udøvelse og anvendelsen heraf
ES2088128T3 (es)	1996-08-01	Aminosulfonilureas inhibidoras de acat.
UA66757C2 (en)	2004-06-15	Ophthalmologic composition of carbonic anhydrase inhibitors, method for treating or preventing macular edema or age-related macular degeneration
DK0655243T3 (da)	2002-10-07	Melatoninderivater til anvendelse ved behandling af søvnlidelser
ATE225171T1 (de)	2002-10-15	Aminosäurederivate zur behandlung von schlaganfall
DK0642791T3 (da)	1999-06-21	Anvendelse af aminosyrer med forgrenet kæde til fremstilling af et lægemiddel til behandling af tardiv dyskinesi
AU2001280093A1 (en)	2002-02-25	Method for the prevention and treatment of retinopathy
EE9700350A (et)	1998-10-15	COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod
DE69412178D1 (de)	1998-09-10	Apparat zur Behandlung von Lagen
DK0968174T3 (da)	2003-05-12	Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok
TR199801801T2 (xx)	1998-12-21	Madde k�t�ye kullan�m�n�n tedavisi.
EP1009421A4 (en)	2001-04-18	METHODS AND COMPOSITIONS FOR IMPROVING HEALING INJURIES
NO984198L (no)	1998-11-02	FremgangsmÕte for behandling av aggresjon
WO2002005796A3 (en)	2002-09-06	Use of a spla2 inhibitor for the treatment of sepsis
SE9602145D0 (sv)	1996-05-31	New improved formulation for treatment of thromboembolism
RU94042315A (ru)	1996-09-20	Способ лечения язвенной болезни желудка и двенадцатиперстной кишки